Reckitt Benckiser Group plc

$ 12.43 0.81 %

Reckitt Benckiser Group plc (RBGLY) is a leading international producer and marketer of consumer health, hygiene, and nutrition products. The company boasts a significant global footprint, with operations spanning key markets such as the United Kingdom, United States, China, and India, among others worldwide. Its extensive product portfolio is divided across several categories. In the consumer health sector, Reckitt provides solutions for various needs, including skincare for blemishes (Clearasil), disinfectants and first aid items (Dettol), sexual health and intimacy products (Durex, K-Y), digestive aids (Gaviscon, Digestive Advantage), and a wide range of respiratory care products for cough, cold, and sinus relief (Mucinex, Delsym, Cepacol). The company also offers pain management solutions (Nurofen, Biofreeze), general wellness supplements like vitamins, minerals, and specialized nutrition for adults and infants (Airborne, Mead Johnson, Move Free, Enfamil, Nutramigen, MegaRed, Neuriva, Bodi-Ome), and depilatories for hair removal (Veet). For household care and hygiene, Reckitt manufactures an array of essentials. These include air fresheners (Air Wick), water treatment additives (Calgon), surface and general home cleaners (Cillit Bang, Easy-Off), dishwashing products (Finish), toilet sanitation solutions (Harpic), pest control items (Lysol, Mortein), laundry detergents and stain removers (Vanish, Woolite, Botanical Origin), and specialized products like septic tank treatments (RID-X). Reckitt Benckiser Group plc was established in 1819 and currently has its corporate headquarters located in Slough, United Kingdom.

CEO: Kristoffer Loe Licht - https://www.reckitt.com

Price objectif

-

Recommandation

Hold

DCF

$ 44.21

Loading data...

RBGLY vs S&P500

Loading data...

No data available.

Quick ratio

0.63

indicates that the company may have difficulty covering its short-term debts with its readily available assets.

P/E ratio

9.49

may indicate that the company is undervalued or has poor growth prospects.

EPS

1.31

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

45.27 %

is generally considered excellent, indicating that the company is generating strong profits with its equity.

ROIC

18.30 %

generates a return higher than the cost of its capital, thereby creating value for its investors.

WACC

4.85

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

1.09

means it relies more on debt, which can increase financial risk.

Free cash flow per share

2.22

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

31.05 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
8 indicates good financial health
Altman score
3.52 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.29 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.34 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.